Three scientists—Karl Deisseroth (US), Peter Hegemann (Germany), and Georg Nagel (Germany)—have been awarded the 2026 Nobel Prize in Physiology or Medicine for their pioneering work in optogenetics, a technique that uses light to control nerve cell activity in the brain. The announcement was made Monday at the Karolinska Institute in Stockholm, marking the start of Nobel Week.
The Nobel Assembly praised their research for opening a new era in neuroscience, enabling scientists to study the neural circuits underlying specific behaviors, memories, and emotions. The method has been widely adopted in laboratories worldwide to investigate neurological and psychiatric disorders.
The prize recognizes their discovery and development of light-gated ion channels, which allow researchers to activate or deactivate individual nerve cells with precision. This technology has been used to map brain functions and explore potential treatments for conditions such as visual impairment and psychiatric diseases.
How the Discovery Unfolded
The research began with Dr. Hegemann’s study of green algae, which naturally move toward light. He and Dr. Nagel identified a protein in the algae that responds to blue light by opening an ion channel, generating an electrical impulse. This protein, later named channelrhodopsin, was the foundation for making other cells light-sensitive.
Dr. Deisseroth then adapted this discovery to neuroscience by inserting the gene for channelrhodopsin into nerve cells, creating a light-controlled switch. This allowed researchers to turn specific neurons on or off in living animals, including mice, providing unprecedented insights into brain function.
The Nobel committee highlighted that optogenetics has become a cornerstone of modern neuroscience, with applications ranging from basic research to potential clinical therapies.
Impact on Medicine and Research
Optogenetics has revolutionized the study of brain circuits, offering a way to isolate and manipulate neural pathways linked to behavior and disease. Researchers are now using the technique to explore treatments for conditions such as:
- Parkinson’s disease
- Epilepsy
- Depression
- Visual impairment
The Nobel Assembly noted that the method has already led to new discoveries about how memories form and how sensory information is processed. In clinical settings, scientists are testing its potential to restore vision in patients with certain types of blindness.
Reactions and Recognition
Dr. Deisseroth, a professor at Stanford University, described receiving the news as surreal. He told reporters he had been working late when he received the call from the Nobel committee. "No real sleep was achieved," he said.
Thomas Perlmann, secretary of the Nobel medicine committee, confirmed that all three laureates were reached by phone shortly after the announcement. The prize includes a 12 million Swedish kronor (approximately $1.2 million) award, shared equally among the winners.
The Nobel Prize in Physiology or Medicine is the first of six awards to be announced this year, followed by the physics, chemistry, literature, peace, and economics prizes over the coming week.